Skip to content

Self-expandable Metal Stent (SEMS) Endoscopic Placement for Malignant Colonic Obstruction Therapy

Randomized Non-inferiority Single-center Prospective Trial of Malignant Colonic Obstruction Therapy With Self-expandable Metal Stent (SEMS) Endoscopic Placement or Stoma Formation.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05643989
Acronym
PATENCY
Enrollment
56
Registered
2022-12-09
Start date
2019-11-01
Completion date
2023-05-11
Last updated
2022-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms,Colorectal

Brief summary

Compare the effectiveness of Self-expandable metal stent (SEMS) and diverting stoma formation for the bowel preparation as a bridge to surgical treatment of patients with MCO.

Detailed description

Surgical treatment of MCO is associated with high mortality and frequent development of postoperative complications. Stoma formation is the traditional method of urgent treatment of MCO. Currently there are more than 150 methods of colorectal stomas formation, but all of themare associated with a high risk of complications (10-20%), inclusively both early and late postoperative period. It results in longerhospital stay and requires additional financial expenses, also reoperations can be fatal for patients. Analysis of recent publications devoted to the treatment of MCO shows increasing implemented of new strategies of patents management, such as fast track surgery, or fast track recovery strategy in clinical practice. Minimally invasive endoscopic procedures as a first stage of MCO treatment leads to transformation of previously performed multi-stage surgical interventions into one - stage. Development of up-to-date endoscopic science and technology provides a wide usage ofself-expandable metal stent (SEMS) in clinical practice. This strategy helps to avoid stoma formation or emergency surgery, becoming a bridge to a radical surgery. There are currently no studies directly comparing discharge stoma with endoscopic self-expandable metal stenting in preparation for colorectal cancer radical surgery.

Interventions

PROCEDUREStoma formation

Trocar placement: the optical trocar (10 mm) will be inserted just near umbilicus . An abdominal revision is performed to determine the location of the tumor. Colon in 10 sm proximally to tumor is prepared for the discharge stoma formation. In the corresponding location on the anterior abdominal wall is formed incision of skin and subcutaneous tissue to the aponeurosis, the cut length is 2.5 sm. After that, aponeurosis crucial incision is performed. The previously prepared colon is brought out to the anterior abdominal wall with the help of a grasper. Discharge stoma is attached to a holding device; colon is fixed by the interrupted sutures (Polysorb 3-0). In the operating room, the stoma is opened, the intestinal patency is checked in both directions, and hemostasis is revealed. With the help of optics, the presence of intestinal tension is checked; if necessary, the colon is additionally mobilized.

PROCEDUREEndoscopic self-expandable metal stent placement

The colonoscope is passed to the distal edge of the tumor and a biopsy of the tumor is performed (if the tumor has not previously been verified). Through the tumor stenosis radioscopically guided metal conductor with atraumatic distal end installs in the proximal colon. A covered or partially covered metal self- expanding stent is placed in the area of tumor stenosis by the conductor, symmetrically in relation to the area of tumor stenosis. Radioscopically and endoscopically guided disclosure of a SEMS is performed immediately after which there is an abundant discharge of gases and intestinal contents. Upon completion of the procedure, the patient is transferred to the patient's room. The next day, a control X-ray of the abdomen is taken.

Sponsors

Russian Society of Colorectal Surgeons
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Patients are 18 years old or older 2. Stage I-IV according to TNM classification 3. Patients with malignant colonic obstruction 4. Overall health status according to ASA classification: I-III 5. Overall health status according to Charlson comorbidity index ≤ 8 points 6. Signed informed consent with agreement to attend all study visits 7. The patient is not pregnant

Exclusion criteria

1. Inflammatory bowel disease 2. Acute purulent process in the abdominal cavity 3. The patient wants to withdraw from the clinical trial 4. Loss to follow-up

Design outcomes

Primary

MeasureTime frameDescription
Bowel preparation (absence of feaces) according to Boston Bowel Preparation Scaleon the 3rd day after obstruction treatment (SEMS or stoma formation)Evaluated via colonoscopy in colon and rectum distal to the tumour. Total score of bowel preparation measured from 0 to 9. The maximum BBPS score for a perfectly clean colon without any residual liquid is 9 and the minimum BBPS score for an unprepared colon is 0. This is evaluated by the endoscopist

Secondary

MeasureTime frameDescription
Early postoperative complications rate after stoma formation or stent placementup to 7 days after procedureThe rate of complications after the procedure
Length of hospital stay after stoma formation or stent placement30 days after procedureNumber of days spent in hospital after procedure
Quality of life before and after stoma formation or stent placement-1 day (before procedure), 3rd and 7th day after procedureMeasured by patient-reported SF-36 scale before and after procedure
Operation time of resectional surgery1 day (the day of tumor resection surgery )The duration of surgical procedure in minutes
Stoma formation rate1 day (the day of tumor resection surgery )The percentage of patients who had preventive or definitive stoma during resectional surgery in the SEMS group
Intraoperative complications rate during stoma formation or stent placement1 day (the day of procedure)The rate of complications during the procedure
Early postoperative complications rate after resectional surgery30 days after resectional surgeryThe rate complications after tumor resection surgery
Length of hospital stay after resectional surgery30 days after resectional surgeryNumber of days spent in hospital after tumor resection surgery
Intraoperative complications rate during resectional surgery1 day (the day of resectional surgery)The rate of complications during tumor resection surgery
Late complications rate during resectional surgery31-90 days after tumor resection surgeryThe rate of complications after tumor resection surgery
Stoma reversal rate1 day (the day of tumor resection surgery )The rate of previously formed stoma reversal simultaneously with tumor resection

Countries

Russia

Contacts

Primary ContactIrina Gorovaia, MD
rudenko@kkmx.com+79175998459
Backup ContactInna Tulina, MD
tulina@kkmx.ru+79264086672

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026